Dr. Gautam Thor, CEO and STTR P.I., has a Ph.D. in Neurobiology and over 30 years' experience in Vision Research, both in academia as well as in the corporate sector. He has also obtained certification to be a research clinical coordinator with IR8-approved proposals.
Retinal Registry was launched as a sole proprietorship, and, has since been incorporated, to investigate and develop novel vision-related diagnostic test procedures and health care solutions. Our core competencies lie in developing customized testing and interpretation software for a range of ophthalmic and neuro-ophthalmic applications. Retinal Registry has not commercialized or licensed the system or any of its sub-components.